Current status on marine products with reversal effect on cancer multidrug resistance

Ioana Abraham1, Khalid El Sayed2, Zhe-Sheng Chen1

  • 1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.

Marine Drugs
|November 22, 2012
PubMed

Insights

Marine natural products show promise in overcoming cancer multidrug resistance (MDR). These compounds can reverse the effects of ATP-binding cassette (ABC) transporters, enhancing chemotherapy efficacy.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Marine Biology

Background:

  • Tumor cell resistance to anticancer agents, known as multidrug resistance (MDR), hinders chemotherapy success.
  • MDR is often mediated by ATP-binding cassette (ABC) superfamily transporters, including P-glycoprotein (P-gp), MRP1, and BCRP.
  • MDR modulators, such as verapamil and cyclosporin A, can inhibit these drug-efflux pumps.

Purpose of the Study:

  • To review marine natural products with the potential to reverse cancer multidrug resistance.
  • To highlight specific marine compounds and their efficacy as MDR modulators.

Main Methods:

  • Literature review of scientific publications on marine natural products and multidrug resistance.
  • Analysis of studies investigating the reversal effects of marine compounds on cancer cell lines expressing ABC transporters.

Main Results:

  • Several marine natural products exhibit MDR reversal activity.
  • Examples include agosterol A, ecteinascidin 743, sipholane triterpenoids, bryostatin 1, and welwitindolinones.
  • These compounds modulate the activity of key drug-efflux pumps.

Conclusions:

  • Marine natural products represent a promising source of novel MDR modulators.
  • Further research into these compounds could lead to improved cancer chemotherapy strategies.
  • Targeting ABC transporters with marine-derived agents offers a potential avenue to overcome drug resistance.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...